Abstract
following kidney transplantation. Additionally, we Soluble T-cell marker assays investigated whether soluble T-cell markers may consCD-4 and sCD-8 were determined in triplicate by commertribute to a better monitoring of allograft rejection cially available enzyme-linked immunosorbent assay and viral infection in kidney transplant recipients.
( ELISA)-test kits 'cell-free CD-4 test kit' and 'T-8 test kit' ( T Cell Science, Cambridge, MA) according to the manufacturer's instructions with slight modification in terms of the
Subjects and methods
length of the incubation periods. The first monoclonal mouse antibody was coated onto polystyrene microtitre plate wells.
Patients
For sCD-4, 50 ml and for sCD-8 10 ml of standards or plasma samples were added to the wells, washed and incubated with Plasma samples from 19 healthy individuals without impair-a mouse anti-mouse antibody conjugated with horseradish ment of renal function (10 female and nine male) and a peroxidase for the same length of time. After incubation, the mean age of 34 years (range 24-40 years) were examined wells were washed again and a substrate solution of o-(controls). Seventy eight kidney transplant recipients, 25 phenylenediamine was applied. The reaction was stopped females and 53 males with an age range of 23-67 years, were with 2 M H 2 SO 4 following incubation for 45 min, and studied. Seventy six patients had received their first transplant absorbance was measured at 490 nm. The ELISA reader and two patients the second transplant. The mean follow-up Milenia Kinetic EIA System and Kinetic Analyser (DPC, was 43 days post-transplant (range 25-72 days). Patients Los Angeles, CA) were used to determine the standard curve were immunosuppressed with a combination of prednisolone and the sample values. and cyclosporin A (CsA). In 32 patients, azathioprine was
The sIL-2R levels in plasma were measured with a commeradded to a 'triple-therapy' regime because of unstable graft cially available ELISA (Immunotech S.A., Marseilles, function. Anti-rejection therapy commonly consisted of France). Briefly, 50 ml of plasma sample were incubated with methylprednisolone bolus therapy (500 mg i.v. for three 100 ml of anti sIL-2R monoclonal antibody conjugated with consecutive days).
alkaline phosphatase for 120 min at room temperature. The patients could be divided into four groups:
Soluble IL-2R present in the plasma sample bound to Stable graft function. Stable graft function was defined when antibody on the well and, after washing of the unreacted serum creatinine, sIL-2R, urine excretion and ultrasono-materials, 200 ml of vial substrate buffer (pNPP) were added graphy was not pathological and an infection could be for 60 min. Thereafter, the reaction was stopped with 50 ml excluded. Serum creatinine should not exceed 150 mmol/l. of 1 M NaOH and the absorbance was determined at 405 nm. Volume of urine excretion should be >1.8 l/day under constant body weight.
Acute rejection. All cases of acute rejection were documented Statistical analyses with allograft histology. Acute rejection was clinically suspected when the serum creatinine was increased above The median (minimum -maximum) values were calculated 250 mmol/l or showed an increasing tendency of 20 mmol/l for each parameter in each group. The significance of per day, and urine excretion declined. Additionally, plasma differences between groups was calculated using the Mannlevels of sIL-2R increased [26, 27] . Allograft ultrasonography Whitney U test for unpaired data or multivariate analysis (renal enlargement in all dimensions, prominent hypoechoic (ANOVA). The sCD-4/sCD-8 ratio of every patient was pyramids or effacement of renal sinus) and Doppler ultra-calculated. The median (minimum -maximum) of all sonography (resistance index of Pourcelot (RI ) Á0.8 with sCD-4/sCD-8 ratios are shown in Table 3 . an increment of 0.1-0.2/day) showed pathological changes [28] . A renal biopsy was performed in all patients when an acute allograft rejection was clinically suspected. transplantation, an acute interstitial rejection could be diagnosed by graft biopsy. An anti-rejection therapy Samples with 500 mg of methylprednisolone i.v. for three consecutive days was started. Shortly after, the concentraPlasma samples were obtained three times a week. tions of the soluble T-cell markers in plasma decreased, Heparinized blood was collected and stored frozen at −20°C whereas serum creatinine showed a delayed decrease.
Results

CMV
after centrifugation.
The second patient ( Figure 2 ) had also a normal graft function and was doing well until 5 weeks after Creatinine measurement transplantation. Thereafter, sCD-4 and sCD-8 plasma concentrations increased and a delayed serum creatinCreatinine was measured with a Beckman creatinine analyser ine elevation followed. However, in contrast to the according to Jaffé's test. A 25 ml aliquot of plasma was added previously described patient, sCD-8 showed a more to a modified Jaffé solution. The increase in absorption was measured during 25.6 s at a wavelength of 520 nm.
pronounced increase compared with sCD-4. A renal On the 24th day after kidney transplantation, serum creatinine began to increase. Four days later, an allograft rejection could be verified by means of biopsy. An anti-rejection therapy with methylprednisolone i.v. for 3 days was started, and 6 days later the serum creatinine began to decline. Characteristically, the plasma levels of sCD-4 and sCD-8 increased shortly before serum creatinine and decreased immediately after successful anti-rejection therapy.
allograft biopsy was performed and an acute rejection sCD-8 showed significant higher plasma concentrations in cases of CMV infection compared with cases of or CsA nephrotoxicity could be excluded. The patient developed fever (40°C ) and the laboratory tests acute rejection. Soluble T-cell markers of healthy individuals showed no significant differences compared revealed a leukopenia (2.1×109/l ), anaemia (haemoglobin 8.5 g/dl ) and an increase in AST (90 U/l ) and with transplant recipients with stable graft function.
During acute allograft rejections, the sCD-4/sCD-8 ALT (140 U/l ). The diagnosis of CMV infection was made by the detection of specific CMV-pp65-EA in ratio in plasma increased, during CMV infections the sCD-4/sCD-8 ratio decreased ( Table 3 ). The sensitivblood specimens. The immunosuppressive regimen was reduced and ganciclovir (adjusted for renal dysfunc-ity, specificity and predictive values of sCD-4 and sCD-8 are shown in Table 4 . tion) was administered for 15 days. The clinical symptoms regressed, and sCD-4 and sCD-8 decreased followed by a delayed reduction of serum creatinine.
Discussion
Patients with stable allograft function showed plasma sCD-4 and sCD-8 levels in the range of those of healthy persons with normal kidney function. In As a sign of early activation of T lymphocytes during episodes of acute rejection and viral infection following cases of acute allograft rejection, sIL-2R (data not shown), sCD-4 and sCD-8 levels increased significantly renal transplantation, significantly elevated plasma levels of sCD-4 and sCD-8 were found. Soluble CD-4 compared with cases with stable allograft function ( Tables 1 and 2 ). Soluble CD-4 showed a more pro-showed a 3.2-fold increase during acute allograft rejection with no further significant difference from episodes nounced increase in cases of acute rejection than did sCD-8. CMV infections also caused a significant incre-of CMV infections. Soluble CD-8, however, was remarkably elevated in plasma during CMV infections ment of sCD-4 and sCD-8 plasma levels compared with cases with stable graft function. Additionally, (3.2-fold) compared with acute rejection episodes A delayed increment of serum creatinine followed. By means of allograft biopsy, an acute allograft rejection or CsA nephrotoxicity could be excluded. A CMV infection, however, could be diagnosed by the detection of specific CMV-pp65EA in blood specimens. In the course of ganciclovir therapy, sCD-4 and sCD-8 decreased followed by a delayed reduction of serum creatinine. The sCD-4 plasma levels were significantly elevated during acute rejection and infection compared with cases with stable graft function The sCD-8 plasma levels were significantly elevated during acute rejection and infection compared with cases with stable graft function (P<0.001*). There was no significant difference between acute rejection and infection. CsA nephrotoxicity induced no significant (P<0.001*). Additionally, there was a significant difference between acute rejection and viral infection (P<0.005**). CsA nephrotoxicity sCD-4 changes in plasma.
induced no significant sCD-4 changes in plasma.
(1.5-fold ). Thus, the sCD-4/sCD-8 ratio in plasma increased in cases of acute allograft rejections and for initiating graft rejection [29, 30] . Biopsy studies revealed that both CD4+ and CD8+ T cells infiltrate decreased during CMV infections as a sign of activation of different T-cell subsets.
allograft tissue with a different pattern in the course of acute rejection. However, the relative proportions These data underline the importance of CD4+ cells to the distinction between allograft rejection or viral infection and CsA nephrotoxicity in patients suffering
The sCD-4/sCD-8 ratio increased significantly (P<0.05) during acute allograft rejection. Additionally, there was a significant differ-from an acute deterioration in allograft function.
ence (P<0.05) between acute allograft rejection and CMV infections.
Different individual renal function might influence the basal level of soluble T-cell markers. This might be responsible for the overlapping of the different of both T-cell subsets vary between different reports study groups. Studies regarding soluble IL-2R demon-[for review, see 2]. Peripheral blood lymphocyte anastrated that basal plasma levels of soluble T-cell lysis by serial flow cytometry following renal transmarkers are influenced by kidney function [40, 41] . plantation failed to differentiate between lymphocyte Therefore, the authors recommended serial measureactivation indicative of acute allograft rejection or viral ments of soluble IL-2R to increase the sensitivity and infection [31, 32] . This failure could be accounted for specificity [40] . From our data regarding sCD-4 and by the poor correlation between peripheral blood sCD-8, a similar conclusion can be drawn. lymphocyte findings and the events within the renal
The investigation of soluble T-cell markers and their graft [33] . Therefore, we assume that the evaluation role in immunological events leads to the questions of of soluble T-cell markers, especially of sCD-4, is a where they originate and what is their function. The superior indicator to flow cytometric analysis of perimechanism of release of sCD-4 and sCD-8 is not pheral blood lymphocytes in cases of acute allograft known, but there are several possibilities. The shedding rejection.
of cell surface molecules could be a part of their In contrast to allograft rejection, a decreased normal turnover [15] , or molecules initially present in CD4/CD8 T-cell ratio was found in blood during the cell membrane could be removed by enzymatic CMV infections [34, 35] . Preceding other manifestacleavage [42, 43] . Another possibility is that through tions of CMV infection in immuno-compromised alternative splicing of mRNA, activated cells synthesize patients, CD4/CD8 inversion turned out to be the distinct soluble molecules, predetermined to be most reliable and earliest indicator of infection [34, 35] .
secreted; this mechanism is thought to account for These data show that especially CD8+ T lymphocytes sCD-8 [44, 45] . Elevated concentrations of soluble increase during systemic CMV infections. Analysis of T-cell markers may represent a sensitive marker for the peripheral blood CD8+CD38+ subset by dualthe level of T lymphocyte activation [15, 46 ] . Our data colour cytometry promises to be a sensitive method to support this thesis. However, the immunological funcmonitor CMV infection in kidney transplant recipients tion of the soluble T-cell markers remains uncertain. [36 ] . These results are in accordance with our observaIt is possible that sCD-8 exerts an important immunortion that especially sCD-8 was remarkably increased egulatory function. It is conceivable that soluble T-cell in the plasma of patients with CMV infection. markers could compete with cellular CD4 or CD8 for Comparable results were found in a study with liver interactions with MHC molecules of allograft or antitransplant recipients [37] . Thus, in cases of systemic gen-presenting cells and effectively interfere with immunological reactions, such as systemic viral infec-T-lymphocyte-target cell interactions. In this way, they tions, peripheral blood lymphocyte findings might could be immunosuppressive and decrease the acute reflect the immunological events. Therefore, the anagraft rejection. A similar function was demonstrated lysis of soluble T-cell markers is not superior to flow for soluble tumour necrosis factor receptors cytometric analysis of peripheral T lymphocytes in cases of CMV infections. These data confirm that the (sTNF-RS ) [47] . In addition, sCD-4 induced a migra- In conclusion, the present study demonstrates that 
